Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $287,616 - $340,578
4,200 New
4,200 $302,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $413,934 - $455,886
-5,700 Reduced 32.02%
12,100 $932,000
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $1.73 Million - $1.95 Million
-29,200 Reduced 62.13%
17,800 $1.12 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1.27 Million - $1.44 Million
22,000 Added 88.0%
47,000 $32,000
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $21.8 Million - $25.8 Million
-509,700 Reduced 95.32%
25,000 $1.27 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $21.9 Million - $26.1 Million
484,600 Added 967.27%
534,700 $25.5 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $1.21 Million - $1.57 Million
-24,900 Reduced 33.2%
50,100 $2.6 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $3.09 Million - $3.49 Million
56,000 Added 294.74%
75,000 $4.66 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $1.14 Million - $1.31 Million
19,000 New
19,000 $1.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.